Financial Management Professionals’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.7K | Sell |
60
-28
| -32% | -$12.5K | ﹤0.01% | 365 |
|
|
2025
Q1 | $42.7K | Buy |
88
+15
| +21% | +$7.27K | 0.01% | 284 |
|
|
2024
Q4 | $29.4K | Buy |
73
+3
| +4% | +$1.21K | ﹤0.01% | 342 |
|
|
2024
Q3 | $33K | Buy |
70
+4
| +6% | +$1.89K | ﹤0.01% | 330 |
|
|
2024
Q2 | $31K | Hold |
66
| – | – | ﹤0.01% | 325 |
|
|
2024
Q1 | $28K | Sell |
66
-10
| -13% | -$4.24K | ﹤0.01% | 365 |
|
|
2023
Q4 | $31K | Buy |
76
+13
| +21% | +$5.3K | 0.01% | 334 |
|
|
2023
Q3 | $22K | Hold |
63
| – | – | ﹤0.01% | 362 |
|
|
2023
Q2 | $22K | Buy |
63
+7
| +13% | +$2.44K | ﹤0.01% | 388 |
|
|
2023
Q1 | $18K | Sell |
56
-17
| -23% | -$5.46K | ﹤0.01% | 451 |
|
|
2022
Q4 | $21K | Buy |
73
+14
| +24% | +$4.03K | ﹤0.01% | 364 |
|
|
2022
Q3 | $17K | Hold |
59
| – | – | ﹤0.01% | 386 |
|
|
2022
Q2 | $17K | Buy |
59
+20
| +51% | +$5.76K | ﹤0.01% | 390 |
|
|
2022
Q1 | $10K | Buy |
39
+37
| +1,850% | +$9.49K | ﹤0.01% | 536 |
|
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 1101 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 1060 |
|
|
2021
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 966 |
|
|
2021
Q1 | – | Sell |
-40
| Closed | -$9K | – | 723 |
|
|
2020
Q4 | $9K | Sell |
40
-139
| -78% | -$31.3K | ﹤0.01% | 386 |
|
|
2020
Q3 | $49K | Sell |
179
-1
| -0.6% | -$274 | 0.02% | 208 |
|
|
2020
Q2 | $52K | Buy |
+180
| New | +$52K | 0.02% | 200 |
|